Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

295 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host.
Choi B, Choudhary MC, Regan J, Sparks JA, Padera RF, Qiu X, Solomon IH, Kuo HH, Boucau J, Bowman K, Adhikari UD, Winkler ML, Mueller AA, Hsu TY, Desjardins M, Baden LR, Chan BT, Walker BD, Lichterfeld M, Brigl M, Kwon DS, Kanjilal S, Richardson ET, Jonsson AH, Alter G, Barczak AK, Hanage WP, Yu XG, Gaiha GD, Seaman MS, Cernadas M, Li JZ. Choi B, et al. Among authors: sparks ja. N Engl J Med. 2020 Dec 3;383(23):2291-2293. doi: 10.1056/NEJMc2031364. Epub 2020 Nov 11. N Engl J Med. 2020. PMID: 33176080 Free PMC article. No abstract available.
Clinical characteristics and outcomes of patients with coronavirus disease 2019 (COVID-19) and rheumatic disease: a comparative cohort study from a US 'hot spot'.
D'Silva KM, Serling-Boyd N, Wallwork R, Hsu T, Fu X, Gravallese EM, Choi HK, Sparks JA, Wallace ZS. D'Silva KM, et al. Among authors: sparks ja. Ann Rheum Dis. 2020 Sep;79(9):1156-1162. doi: 10.1136/annrheumdis-2020-217888. Epub 2020 May 26. Ann Rheum Dis. 2020. PMID: 32457048 Free PMC article.
Response to: 'COVID-19 in patients with rheumatological diseases treated with Anti-TNF' by Brito et al and 'Clinical characteristics and outcomes of patients with COVID-19 and rheumatic disease in China 'hot spot' versus in US 'hot spot': similarities and differences' by Zhao et al.
D'Silva KM, Serling-Boyd N, Wallwork R, Hsu T, Sparks JA, Wallace ZS. D'Silva KM, et al. Among authors: sparks ja. Ann Rheum Dis. 2021 May;80(5):e64. doi: 10.1136/annrheumdis-2020-218196. Epub 2020 Jun 16. Ann Rheum Dis. 2021. PMID: 32546600 No abstract available.
Incident systemic rheumatic disease following COVID-19.
Hsu TY, D'Silva KM, Patel NJ, Fu X, Wallace ZS, Sparks JA. Hsu TY, et al. Among authors: sparks ja. Lancet Rheumatol. 2021 Jun;3(6):e402-e404. doi: 10.1016/S2665-9913(21)00106-5. Epub 2021 Apr 6. Lancet Rheumatol. 2021. PMID: 33842894 Free PMC article. No abstract available.
Laboratory trends, hyperinflammation, and clinical outcomes for patients with a systemic rheumatic disease admitted to hospital for COVID-19: a retrospective, comparative cohort study.
Hsu TY, D'Silva KM, Patel NJ, Wang J, Mueller AA, Fu X, Prisco L, Martin L, Vanni KMM, Zaccardelli A, Cook C, Choi HK, Zhang Y, Gravallese EM, Wallace ZS, Sparks JA. Hsu TY, et al. Among authors: sparks ja. Lancet Rheumatol. 2021 Sep;3(9):e638-e647. doi: 10.1016/S2665-9913(21)00140-5. Epub 2021 May 28. Lancet Rheumatol. 2021. PMID: 34095857 Free PMC article.
295 results